Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report.

Cases Journal
Kumar GauravMukta Panda

Abstract

Primary signet ring cell carcinoma of urinary bladder is a rare type of bladder tumor and carries a very high mortality rate. It may have a clinical presentation similar to common diseases like Benign Prostatic Hypertrophy (BPH) and the management options are extremely limited. We report a case of 58 year old Caucasian male who presented with a 5 month history of increased frequency of urination, nocturia and weight loss without any fever or hematuria. He was found to have an increased creatinine of 2.8 mg/dl and a prostate specific antigen level of 0.18 ng/ml. His azotemia was thought to be secondary to BPH. A foley catheter was initially placed with a plan for outpatient follow up. On removal of the catheter his problems persisted and he returned to the hospital. Diagnostic work up including abdominal ultrasonography, computed tomography (CT) scan, retrograde pyelogram, cystography and cystoscopic biopsies revealed the diagnosis of primary signet ring cell carcinoma of urinary bladder. Although cystectomy was planned, our patient passed away before this could be done.

References

May 1, 1988·Urology·S A BernsteinW F Whitmore
Jan 1, 1993·Urology·L FiterL Gómez Tejeda
Apr 1, 1997·Scandinavian Journal of Urology and Nephrology·S HolmängS L Johansson
Mar 22, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·S YamamotoM Mochizuki
Sep 26, 2013·Orbit·Jennifer S L TanThomas G Hardy

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies
coronary artery bypass

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.